about
Newer positron emission tomography radiopharmaceuticals for radiotherapy planning: an overviewPhase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients.Subtle clinical signs of a meningioma in an adult: a case report.An observational study on the expression of cyclooxygenase-2 in meningioma.The WNKs: atypical protein kinases with pleiotropic actions.Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.Chk2-mediated G2/M cell cycle arrest maintains radiation resistance in malignant meningioma cells.DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.Impaired survival and long-term neurological problems in benign meningioma.The current status of 5-ALA fluorescence-guided resection of intracranial meningiomas-a critical reviewBrain meningioma invading and destructing the skull bone: replacement of the missing bone in vivo.Metastatic meningioma: positron emission tomography CT imaging findings.Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.Medical treatment of recurrent meningiomas.A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt/β-catenin signaling pathway.Re-evaluation of cytostatic therapies for meningiomas in vitro.Cavernous sinus syndrome: need for early diagnosis.Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment ActAn elusive cause of pleural effusion.Modulation of Dkk-3 and claudin-5 as new therapeutic strategy in the treatment of meningiomas.PIK3CA mutations in meningioma.Ultrasound-Guided Intratumoral Radiofrequency Ablation Coagulation to Facilitate Meningioma Resection: Preliminary Experience.Peritumoral brain edema in angiomatous supratentorial meningiomas: an investigation of the vascular endothelial growth factor A pathway.Clinicopathological evaluation of cyclooxygenase-2 expression in meningioma: immunohistochemical analysis of 76 cases of low and high-grade meningioma.Systemic therapy for recurrent meningioma.Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.Emerging Medical Treatments for Meningioma in the Molecular Era
P2860
Q26767172-5208BA98-BC32-4F75-8490-9BFD6F13055FQ30361848-3834F24E-F3B8-47A3-ACD5-494AE9D04C2EQ30393860-FB21D510-417F-4D94-8B5F-720BE33A37E0Q30455709-F522E723-07F2-4CF5-95DF-3F20EAEB2DB3Q34003018-E473BE36-D137-4911-84AF-5C94C3AEA7BEQ34447735-0735A4A0-92D7-4A96-8CC9-3651D24A7296Q34560188-977238B5-40CD-4F5B-A20D-DE0470AA2EB1Q35106253-49932F6F-D8A0-488A-A5DC-55E311F620B5Q35387417-B47FFBCE-3A2C-4585-9FB2-7FEB6F46CCF6Q35584376-64AF81C4-1AC8-4527-8202-A038A9FACD34Q35914505-FB5DE43E-81D7-4138-932B-4FC67614C5B9Q36034350-9FE550E2-A936-40CB-80DF-F961307348B1Q36177827-688E6480-3248-4A22-89B3-1CDF14BAE2DBQ36324533-816E69D0-E1E1-44A6-BB2E-A6A7995C268FQ36943867-3E3C4F81-CFFB-4F91-924F-905A8BC11998Q37939997-98C946D7-A9E0-4C39-BFC0-017AD3179BEDQ38888517-7A771D34-5EDE-456C-BC84-9A9BC682864FQ38996146-64F3DD7C-BC11-4A3E-B299-5835EA39FAFDQ39270629-A70DB825-97FB-467D-8955-6851F788EB09Q41074722-3452E942-7AE9-4C4E-A54C-214216E44AC7Q42006939-69E1D1DD-5229-4DD0-ADF0-A248D24B9FEAQ42366613-BAD3C03F-6949-4F12-B678-255725697ACAQ42908544-2CE2CF86-45B2-486D-8725-BFECA4F73B50Q48099428-D0E5D17E-67B4-478C-850C-5A2904214158Q48168487-AF652F93-2E34-439A-835D-D072C4613211Q48249218-C767F1B0-5215-4301-BAE1-1744C950FA4DQ48787594-5A1C5740-1B70-4531-91B5-2C6E14027154Q50664835-653784D5-6599-4C39-BED5-406BD7F5A341Q52581527-11F38363-8F23-4D4E-BD14-2A91780528A6Q58798211-41BB2784-AF0A-4E49-A89D-E1C9B0BA4C57
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in meningioma therapy.
@en
Advances in meningioma therapy.
@nl
type
label
Advances in meningioma therapy.
@en
Advances in meningioma therapy.
@nl
prefLabel
Advances in meningioma therapy.
@en
Advances in meningioma therapy.
@nl
P2093
P2860
P1476
Advances in meningioma therapy.
@en
P2093
Andrew D Norden
Jan Drappatz
Patrick Y Wen
P2860
P2888
P304
P356
10.1007/S11910-009-0034-5
P577
2009-05-01T00:00:00Z